99 related articles for article (PubMed ID: 3738400)
21. Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor--positive breast cancer.
Fink AK; Gurwitz J; Rakowski W; Guadagnoli E; Silliman RA
J Clin Oncol; 2004 Aug; 22(16):3309-15. PubMed ID: 15310774
[TBL] [Abstract][Full Text] [Related]
22. Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patients.
Cohen I; Figer A; Tepper R; Shapira J; Altaras MM; Yigael D; Beyth Y
Gynecol Oncol; 1999 Feb; 72(2):202-7. PubMed ID: 10021302
[TBL] [Abstract][Full Text] [Related]
23. Trial of tamoxifen at a dose of 40 mg daily after disease progression during tamoxifen therapy at a dose of 20 mg daily.
Stewart JF; Minton MJ; Rubens RD
Cancer Treat Rep; 1982 Jun; 66(6):1445-6. PubMed ID: 7044536
[No Abstract] [Full Text] [Related]
24. [Clinical evaluation of NK 622 (toremifene citrate) in advanced or recurrent breast cancer--a comparative study by a double blind method with tamoxifen].
Nomura Y; Tominaga T; Abe O; Izuo M; Ogawa N
Gan To Kagaku Ryoho; 1993 Feb; 20(2):247-58. PubMed ID: 8434963
[TBL] [Abstract][Full Text] [Related]
25. Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer.
Budd GT; Adamson PC; Gupta M; Homayoun P; Sandstrom SK; Murphy RF; McLain D; Tuason L; Peereboom D; Bukowski RM; Ganapathi R
Clin Cancer Res; 1998 Mar; 4(3):635-42. PubMed ID: 9533531
[TBL] [Abstract][Full Text] [Related]
26. Adenofibroma of the endometrium after tamoxifen therapy for breast cancer: MR findings.
Oshima H; Miyagawa H; Sato Y; Satake M; Shiraki N; Nishikawa H; Arakawa A; Ogino H; Hara M
Abdom Imaging; 2002; 27(5):592-4. PubMed ID: 12173004
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of postmenopausal breast cancer patients following discontinuation of tamoxifen therapy.
Markovitch O; Tepper R; Fishman A; Aviram R; Cohen I
Maturitas; 2008 Apr; 59(4):387-93. PubMed ID: 18490117
[TBL] [Abstract][Full Text] [Related]
28. Tamoxifen approved for premenopausal women with advanced breast cancer.
Oncology (Williston Park); 1989 Jun; 3(6):44. PubMed ID: 2641502
[No Abstract] [Full Text] [Related]
29. Sequential or concurrent tamoxifen and radiotherapy: to see or not to see--that is the question!
Bentzen SM; Yarnold JR
J Clin Oncol; 2005 Sep; 23(25):6266-7; author reply 6267. PubMed ID: 16135499
[No Abstract] [Full Text] [Related]
30. Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: the Pre-Operative "Arimidex" Compared to Tamoxifen (PROACT) trial.
Cataliotti L; Buzdar AU; Noguchi S; Bines J; Takatsuka Y; Petrakova K; Dube P; de Oliveira CT
Cancer; 2006 May; 106(10):2095-103. PubMed ID: 16598749
[TBL] [Abstract][Full Text] [Related]
31. Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93.
; Colleoni M; Gelber S; Goldhirsch A; Aebi S; Castiglione-Gertsch M; Price KN; Coates AS; Gelber RD
J Clin Oncol; 2006 Mar; 24(9):1332-41. PubMed ID: 16505417
[TBL] [Abstract][Full Text] [Related]
32. Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients.
Mandalà M; Moro C; Ferretti G; Calabro MG; Nolè F; Rocca A; Munzone E; Castro A; Curigliano G
Anticancer Res; 2001; 21(1B):585-8. PubMed ID: 11299809
[TBL] [Abstract][Full Text] [Related]
33. Aromatase inhibitors and the endometrium.
Cohen I
Maturitas; 2008 Apr; 59(4):285-92. PubMed ID: 18448280
[TBL] [Abstract][Full Text] [Related]
34. Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina.
Bradbury BD; Lash TL; Kaye JA; Jick SS
Cancer; 2005 Mar; 103(6):1114-21. PubMed ID: 15712362
[TBL] [Abstract][Full Text] [Related]
35. Contact plate thermography: a new technique for diagnosis of breast masses.
Goldberg IM; Schick PM; Pilch Y; Shabot MM
Arch Surg; 1981 Mar; 116(3):271-3. PubMed ID: 7469763
[TBL] [Abstract][Full Text] [Related]
36. [The peripheral hormone level in premenopausal patients with benign breast changes and their modification by various hormone therapies].
Bohnet HG; Bertram M
Gynakologe; 1989 Aug; 22(4):255-61. PubMed ID: 2676761
[No Abstract] [Full Text] [Related]
37. [Contact thermography in the differential diagnosis of benign tumors and cancer of the breast].
Geshelin SA; Noskin AL; Kravchenko VA
Vrach Delo; 1989 Aug; (8):103-5. PubMed ID: 2588501
[TBL] [Abstract][Full Text] [Related]
38. [Update in the therapy of fibrocystic mastopathy].
Zanoio L; Zacché G; Mainenti M; Silvestre V
Minerva Ginecol; 1987 Dec; 39(12):833-8. PubMed ID: 3329703
[No Abstract] [Full Text] [Related]
39. [Mastodynia and fibrocystic disease of the breast].
Pons JY
J Gynecol Obstet Biol Reprod (Paris); 1987; 16(1):129. PubMed ID: 3584864
[No Abstract] [Full Text] [Related]
40. Current status of hormonal therapy of fibrocystic breast disease.
Dogliotti L; Fioretti P; Melis GB; Mussa A; Angeli A
Ann N Y Acad Sci; 1986; 464():350-63. PubMed ID: 3089096
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
